Parker AS - Search Results

1

Creation of a primary tumor tissue expression biomarker-augmented prognostic model for patients with metastatic renal cell carcinoma.

Bearrick EN, Packiam V, Bhindi B, Lohse CM, Cheville JC, Mason RJ, Tollefson M, Harrington S, Dong H, Parker AS, Boorjian SA, Thompson RH, Leibovich BC. Bearrick EN, et al. Among authors: parker as. Urol Oncol. 2021 Feb;39(2):135.e1-135.e8. doi: 10.1016/j.urolonc.2020.08.028. Epub 2020 Dec 9. Urol Oncol. 2021. PMID: 33309297

2

Gender, alcohol consumption, and renal cell carcinoma.

Parker AS, Cerhan JR, Lynch CF, Ershow AG, Cantor KP. Parker AS, et al. Am J Epidemiol. 2002 Mar 1;155(5):455-62. doi: 10.1093/aje/155.5.455. Am J Epidemiol. 2002. PMID: 11867357

3

High expression levels of insulin-like growth factor-I receptor predict poor survival among women with clear-cell renal cell carcinomas.

Parker AS, Cheville JC, Janney CA, Cerhan JR. Parker AS, et al. Hum Pathol. 2002 Aug;33(8):801-5. doi: 10.1053/hupa.2002.126186. Hum Pathol. 2002. PMID: 12203212

4

Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials.

Leibovich BC, Blute ML, Cheville JC, Lohse CM, Frank I, Kwon ED, Weaver AL, Parker AS, Zincke H. Leibovich BC, et al. Among authors: parker as. Cancer. 2003 Apr 1;97(7):1663-71. doi: 10.1002/cncr.11234. Cancer. 2003. PMID: 12655523 Free article.

5

Smoking cessation and renal cell carcinoma.

Parker AS, Cerhan JR, Janney CA, Lynch CF, Cantor KP. Parker AS, et al. Ann Epidemiol. 2003 Apr;13(4):245-51. doi: 10.1016/s1047-2797(02)00271-5. Ann Epidemiol. 2003. PMID: 12684190

6

Expression of insulin-like growth factor I receptor and survival in patients with clear cell renal cell carcinoma.

Parker A, Cheville JC, Lohse C, Cerhan JR, Blute ML. Parker A, et al. J Urol. 2003 Aug;170(2 Pt 1):420-4. doi: 10.1097/01.ju.0000071474.70103.92. J Urol. 2003. PMID: 12853790

7

History of urinary tract infection and risk of renal cell carcinoma.

Parker AS, Cerhan JR, Lynch CF, Leibovich BC, Cantor KP. Parker AS, et al. Am J Epidemiol. 2004 Jan 1;159(1):42-8. doi: 10.1093/aje/kwh014. Am J Epidemiol. 2004. PMID: 14693658

8

Pathologic T1 clear cell renal cell carcinoma: insulin-like growth factor-I receptor expression and disease-specific survival.

Parker AS, Cheville JC, Blute ML, Igel T, Lohse CM, Cerhan JR. Parker AS, et al. Cancer. 2004 Jun 15;100(12):2577-82. doi: 10.1002/cncr.20322. Cancer. 2004. PMID: 15197799 Free article.

9

Loss of expression of von Hippel-Lindau tumor suppressor protein associated with improved survival in patients with early-stage clear cell renal cell carcinoma.

Parker AS, Cheville JC, Lohse CM, Igel T, Leibovich BC, Blute ML. Parker AS, et al. Urology. 2005 Jun;65(6):1090-5. doi: 10.1016/j.urology.2004.12.040. Urology. 2005. PMID: 15893810

10

Clear cell renal cell carcinoma: gene expression analyses identify a potential signature for tumor aggressiveness.

Kosari F, Parker AS, Kube DM, Lohse CM, Leibovich BC, Blute ML, Cheville JC, Vasmatzis G. Kosari F, et al. Among authors: parker as. Clin Cancer Res. 2005 Jul 15;11(14):5128-39. doi: 10.1158/1078-0432.CCR-05-0073. Clin Cancer Res. 2005. PMID: 16033827

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

201 results

Search Page

Filters